Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

MRC MHU RDM

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.

© Shutterstock/sciencepics

Read the full press release on the Nucleome Therapeutics website: https://nucleome.com/news-publications/news-nucleome-raises-oversubscribed-series-a/

Tell us your news

Do you have a new publication? Received an award? Contact us to feature your story.

Similar stories